Doug Wilson

Doug Wilson

Direttore Tecnico/Scientifico/R&S presso
Ferghana Partners Group
89 anni
Health Technology
Finance
Consumer Non-Durables

Profilo

Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd. from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd. from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd. from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd. from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.

Posizioni attive di Doug Wilson

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Mainz Consulting Ltd.
Direttore/Membro del Consiglio -
Direttore Tecnico/Scientifico/R&S -

Precedenti posizioni note di Doug Wilson

SocietàPosizioneFine
AFT PHARMACEUTICALS LIMITED Direttore/Membro del Consiglio 05/08/2022
PYC THERAPEUTICS LIMITED Presidente 08/10/2015
SEADRAGON LIMITED Presidente 04/05/2015
ADHERIUM LIMITED Presidente 01/09/2016
Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Doug Wilson

Formazione di Doug Wilson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

27

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Finance

Consumer Non-Durables

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Mainz Consulting Ltd.

  1. Mercati
  2. Insiders
  3. Doug Wilson
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA